25 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34687147 | Inhibition of mevalonate metabolism by statins augments the immunoregulatory phenotype of vascular endothelial cells and inhibits the costimulation of CD4+ T cells. | 2022 Mar | 1 |
2 | 27343379 | Simvastatin requires activation in accessory cells to modulate T-cell responses in asthma and COPD. | 2016 Oct 5 | 2 |
3 | 25659387 | Simvastatin suppresses the proangiogenic microenvironment of human hepatic stellate cells via the Kruppel-like factor 2 pathway. | 2015 Feb | 1 |
4 | 24419251 | Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis. | 2014 Apr | 1 |
5 | 24788303 | Simvastatin modulates cellular components in influenza A virus-infected cells. | 2014 Jul | 1 |
6 | 23950601 | Lymphocyte-suppressing action of simvastatin in patients with isolated hypertriglyceridemia. | 2013 | 1 |
7 | 24159421 | Statin Modulation of Human T-Cell Proliferation, IL-1β and IL-17 Production, and IFN-γ T Cell Expression: Synergy with Conventional Immunosuppressive Agents. | 2013 | 1 |
8 | 23042198 | Simvastatin protects against T cell immune dysfunction in abdominal sepsis. | 2012 Nov | 1 |
9 | 23107042 | Lymphocyte-suppressing and systemic anti-inflammatory effects of high-dose metformin in simvastatin-treated patients with impaired fasting glucose. | 2012 Dec | 1 |
10 | 21268089 | Molecular mechanisms underlying the inhibition of IFN-γ-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs. | 2011 Feb | 2 |
11 | 21276586 | Effect of simvastatin and fenofibrate on cytokine release and systemic inflammation in type 2 diabetes mellitus with mixed dyslipidemia. | 2011 Apr 1 | 1 |
12 | 21440087 | Statins as modulators of colon cancer cells induced cytokine secretion by human PBMC. | 2011 Mar-Jun | 1 |
13 | 20676966 | On the combined effect of statins and lycopene on cytokine production by human peripheral blood cells. | 2010 Sep | 1 |
14 | 19589242 | Simvastatin reduces OX40 and OX40 ligand expression in human peripheral blood mononuclear cells and in patients with atherosclerotic cerebral infarction. | 2009 May-Jun | 1 |
15 | 19886038 | Simvastatin acts as an inhibitor of interferon gamma-induced cycloxygenase-2 expression in human THP-1 cells, but not in murine RAW264.7 cells. | 2009 Aug | 6 |
16 | 18453621 | Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes. | 2008 May 15 | 1 |
17 | 18686224 | Statins decrease the aberrant HLA-DR expression on thyrocytes from patients with Hashimoto's thyroiditis. | 2008 Dec | 1 |
18 | 18791454 | Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells. | 2008 Sep 15 | 1 |
19 | 16439692 | Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. | 2006 Mar 3 | 1 |
20 | 16621994 | Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes. | 2006 May 1 | 1 |
21 | 16682645 | Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells. | 2006 May 16 | 1 |
22 | 16870268 | Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis. | 2006 Sep | 2 |
23 | 15936988 | Simvastatin induces interleukin-18 production in human peripheral blood mononuclear cells. | 2005 Sep | 3 |
24 | 11219190 | The HMG-CoA reductase inhibitor simvastatin inhibits IFN-gamma induced MHC class II expression in human vascular endothelial cells. | 2001 Jan 27 | 3 |
25 | 11397960 | Inhibition of interferon-gamma-mediated microvascular endothelial cell major histocompatibility complex class II gene activation by HMG-CoA reductase inhibitors. | 2001 May 15 | 5 |